The global asparaginase market is witnessing remarkable growth, driven by the rising incidence of hematological cancers and advancements in biopharmaceutical technologies. The asparaginase market is expected to grow from US$ 564.01 million in 2021 to US$ 1,575.62 million by 2028. It is estimated to grow at a CAGR of 16.1% from 2022 to 2028. Asparaginase is a vital enzyme-based chemotherapeutic...